Meniere's Disease and Migraine: Effect of Migraine Medications on Symptoms of Meniere's Disease
The Laryngoscope · 2026
DOI: 10.1002/lary.70578 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Laryngoscope, 2026. Verfasst von Khushi Bhatt und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology-Head and Neck Surgery, University of California, Irvine, California, USA. Hauptthemen laut MEDLINE: Meniere Disease, Migraine Disorders. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCATS NIH HHS, NCRR NIH HHS, National Center for Advancing Translational Sciences.
Abstract (Originalsprache)
Objectives
To observe the incidence of Meniere's disease (MD) and MD‐related symptoms (i.e., aural fullness, tinnitus, hearing loss, and vertigo) between (a) non‐migraine and migraine patients and (b) migraine untreated and migraine treated patients within the TriNetX database.
Methods
We conducted a retrospective cohort study of (a) non‐migraine and migraine patients and (b) migraine treated and untreated patients within the TriNetX database from 2013 till 2025. Patients underwent propensity score matching for sex, age, race, and known lifestyle/disease confounders for MD. Incidence of MD and MD‐related symptoms were evaluated 5 years post index date and beyond 5 years post index date.
Results
Migraine patients demonstrated a greater incidence of MD and MD‐related symptoms 5 years and more than 5 years post index date. Amongst migraine patients, those not receiving treatment demonstrated a lesser predilection (risk ratio [RR] = 0.43, 95% CI: 0.28–0.66) of developing MD than patients receiving treatment. There was no significant difference in the incidence of hearing loss or aural fullness between migraine untreated and treated subgroups. Migraine patients not receiving treatment had an increased risk of experiencing tinnitus (RR = 1.11, 95% CI: 1.03–1.19).
Conclusions
There exists a connection between migraine and MD. Migraine patients receiving migraine treatment are statistically significantly more likely to develop MD compared to non‐migraine patients. These results support the findings of preceding studies that have demonstrated a pathophysiological link between migraine and vestibulocochlear dysfunction. Level of Evidence 3
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Otolaryngology-Head and Neck Surgery, University of California, Irvine, California, USA.
- Department of Biomedical Engineering, University of California, Irvine, California, USA.
- Department of Neurological Surgery, University of California, Irvine, California, USA.
ORCID-Profile: Hamid R Djalilian, Mehdi Abouzari
Förderung
- NCATS NIH HHS
- NCRR NIH HHS
- National Center for Advancing Translational Sciences
Zitieren
APA
Bhatt, K., Ren, Y., Chan, C., Rara, M., Djalilian, H. R., & Abouzari, M. (2026). Meniere's Disease and Migraine: Effect of Migraine Medications on Symptoms of Meniere's Disease. The Laryngoscope. https://doi.org/10.1002/lary.70578
Vancouver
Bhatt K, Ren Y, Chan C, Rara M, Djalilian HR, Abouzari M. Meniere's Disease and Migraine: Effect of Migraine Medications on Symptoms of Meniere's Disease. The Laryngoscope. 2026. doi:10.1002/lary.70578
BibTeX
@article{Bhatt2026,
author = {Bhatt, Khushi and Ren, Yueqi and Chan, Charlotte and Rara, Marianne and Djalilian, Hamid R and Abouzari, Mehdi},
title = {Meniere's Disease and Migraine: Effect of Migraine Medications on Symptoms of Meniere's Disease},
journal = {The Laryngoscope},
year = {2026},
doi = {10.1002/lary.70578}
}
EUVIMED